© 2023 MJH Life Sciences and Medical Economics. All rights reserved.
© 2023 MJH Life Sciences™ and Medical Economics. All rights reserved.
FLORIDA HOSPITAL WATERMAN INC
1000 WATERMAN WAY
2017 has seen two key advancements for diabetes patients, but affordability remains an issue.
Glucose lowering drugs provide additional cardiovascular benefit to patients with diabetes.
Diabetes and high BMI were responsible for an estimated 800,000 new cases of cancer worldwide in 2012.
Study shows that longer sleep duration was associated with reductions in several markers for type 2 diabetes.
Patients at high risk could be identified and targeted for intervention, resulting in the potential for high healthcare cost savings.
More than twice as many adults aged 45 to 65 with diabetes reported skipping doses of medication to save money, according to new data.